Summit Therapeutics SMMT Earnings Call Transcripts

NASDAQ SMMT
$16.95 -0.88 (-4.91%)
As of: Nov 11, 2026 · 11:33 AM EST
2 earnings calls on file for Summit Therapeutics, from Q3 2025 to Q4 2025. Each transcript opens in a new tab.
Latest earnings call

Summit Therapeutics Q4 2025 Earnings Call

Feb 23, 2026 9,805 words · 43 min read
  • David GancarzChief Executive Officer
  • Manmeet SoniPresident and Chief Operating Officer
  • Allen YangChief Medical Officer
  • Bob DugganChairman and Chief Executive Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Summit Therapeutics Earnings Call Transcripts

Calls2
LatestFeb 23, 2026
SinceQ3 2025

Fiscal 2025

All 2 Summit Therapeutics transcripts Register to get access to Summit Therapeutics’s earnings call transcripts.